Press Releases
-
Creative Proteomics Launches Label-free Quantification Service for Advanced Protein Analysis
-
Empower Your Research with Creative Proteomics' Innovative Pull-Down Assay Service
-
Stability Analysis Plays a Crucial Role in Pharmaceutical Formulation, Highlighted by CD Formulation
-
Abzena partners with FDA on publication demonstrating the benefits of the MAPPs assay for immunogenicity
Abzena, a leading CDMO for biologics, collaborates with the FDA on a publication endorsing the MHC Associated Peptide Proteomics (MAPPs) assay for assessing immunogenicity in drug development. The article underscores MAPPs' precision in identifying potential immunogenicity risks in early preclinical stages, reducing the likelihood of anti-drug antibodies (ADAs) and optimizing biologics. Abzena integrates MAPPs into its immunogenicity services, aiming to de-risk drug development. The Chief Scientific Officer, Dr. Campbell Bunce, emphasizes the assay's value in informing drug regions that may induce ADAs. The collaboration aims to expedite safer, more effective therapies for patients
Dec 18, 2023
-
Recipharm harmonizes its global quality operations with Veeva Vault Quality
Hope you are well and are having a great week so far! I just wanted to pass on the latest news from Recipharm, who has chosen Veeva Systems to streamline global quality operations. The move aims to enhance oversight, resource efficiency, validation speed, and inspection readiness. The full release is below. Thank you Charlotte
Dec 18, 2023
-
Alfa Chemistry Leads the Way to Unleash Power of Computational Solutions in Solid State Chemistry for Pharmaceutical Research
-
Oz-UK Ltd announces new low-GWP manufacturing line installation to meet global need for pMDIs ahead of the Kigali Amendment deadline
Oz-UK Ltd announces the installation of its new low-GWP (global warming potential) manufacturing line.
Dec 14, 2023
-
Analyzing Delivery Systems: CD Formulation Introduces In Vitro Testing to Measure Microsphere and Microneedle Release
-
PrecisionLife Project Awarded Innovate UK Grant to Improve Diagnosis and Treatment of ME/CFS and Long Covid
Leading computational biology company PrecisionLife®, which is driving precision medicine in complex chronic diseases, the ME/CFS charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh have been awarded a £622,000 grant by Innovate UK's Advancing Precision Medicine programme to improve diagnosis and treatment for the millions of people affected by ME/CFS and long Covid.
Dec 14, 2023
-
ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas’ LNP formulations
I just wanted to follow up to see if you had received my initial email regarding ReciBioPharm partners with Acuitas Therapeutics? Please let me know if there is any further information you require from me for this.
Dec 14, 2023
-
TransCure bioServices strengthens team with C-suite hire and boosts North American preclinical opportunities
TransCure bioServices has announced the appointment of Céline Pinault as its new Chief Financial Officer.
Dec 12, 2023
-
Joint report from Ashfield Event Experiences, part of Inizio Engage XD, and IPCAA provides insights to drive future medical congress and convention success
I wanted to share some exciting insights from a joint report by Ashfield Event Experiences, part of Inizio Engage XD, and the International Pharmaceutical Congress Advisory Association (IPCAA). This report delves into the evolving landscape of healthcare provider (HCP) behaviors and attitudes towards medical congresses and conventions, particularly in the context of the return of in-person events. The full release is below.
Dec 12, 2023
-
VLPlant™ Is Set to Revolutionize Viral Vaccine Development
-
Ace Neuroscience Launches Drug Development Services for Stroke and Psychiatric Disorders
-
Amerigo Scientific's New Lab Offering: S-Silver SERS Substrates
-
Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics
-
Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant
Please see below news from Recipharm on its collaboration with CRO, Oz-UK to accelerate the development of low global warming pressurised Metered Dose Inhalers (pMDIs). It has also announced the appointment of Simon Gardner, formerly of HFA-152a propellant supplier, Koura to support customers in their transition to greener propellants.
Dec 4, 2023
-
Lightship & Acclinate Introduce Season of Giving — Initiative to Support Communities That Give Time for Clinical Research
As part of this Season of Giving initiative, Lightship and Acclinate are extending an open call for other clinical research industry and health-focused organizations to join them for future events.
Dec 3, 2023
-
X-Chem Announces Achievement of Collaboration Milestone
X-Chem, a global leader in innovative drug discovery services, announces the achievement of a drug discovery milestone, following a partner’s attainment of a development candidate. Relay Therapeutics, a leader in cutting-edge approaches to drug discovery, utilized X-Chem’s DNA-Encoded Library (DEL) platform to perform hit finding intended to discover molecules with differentiated pharmacological properties. The resulting molecule led to a development candidate — a milestone under the companies’ collaboration agreement and to progress in evaluation.
Dec 4, 2023
-
Kindeva Drug Delivery and Orbia Fluorinated Solutions (Koura) Announce Collaboration for Low GWP Propellant Conversion
Kindeva Drug Delivery (Kindeva), a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, and Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) Fluorinated Solutions business (Koura®), a global leader in the development, manufacture, and supply of fluoroproducts and technologies, announced today a co-development collaboration for the conversion from existing marketed pressurised Metered Dose Inhaler (pMDI) products to Koura’s more sustainable and environmentally-conscious medical propellant; HFA 152a, known as Zephex® 152a.
Dec 4, 2023